PRESS RELEASE published on 05/11/2026 at 11:09, 2 months 26 days ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market, targeting niche patient populations and high-need therapeutic areas with a strategic commercial milestone Marinomed Biotech AG Marinosolv Technology Tacrolimus Eyedrops Compounding Market Ophthalmologists
BRIEF published on 04/22/2026 at 09:09, 3 months 14 days ago Marinomed Biotech AG Expands into Compounding Services Global Expansion Marinomed Biotech Marinosolv Technology Compounding Services Customized Medicines
BRIEF published on 04/22/2026 at 09:09, 3 months 14 days ago Marinomed Biotech AG se développe dans le domaine des services de préparation magistrale Expansion Mondiale Technologie Marinosolv Biotechnologie Marinomed Services De Préparation Magistrale Médicaments Personnalisés
PRESS RELEASE published on 04/22/2026 at 09:04, 3 months 14 days ago Marinomed Announces Strategic Expansion into Compounding Services Featuring Marinosolv® Technology Marinomed Biotech AG announces strategic expansion into compounding services with Marinosolv technology, offering personalized medicines for global demand Marinomed Biotech AG Strategic Expansion Marinosolv Technology Compounding Services Personalized Medicines
BRIEF published on 04/13/2026 at 17:07, 3 months 23 days ago Marinomed Biotech AG finalise avec succès son augmentation de capital Augmentation De Capital Confiance Des Investisseurs Bourse De Vienne Actions Émises Biotechnologie Marinomed
BRIEF published on 04/13/2026 at 17:07, 3 months 23 days ago Marinomed Biotech AG Completes Successful Capital Increase Capital Increase Investor Confidence Vienna Stock Exchange Marinomed Biotech Shares Issued
PRESS RELEASE published on 04/13/2026 at 17:02, 3 months 23 days ago Marinomed secures financing through successful capital increase Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF published on 03/23/2026 at 17:49, 4 months 14 days ago Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
BRIEF published on 03/23/2026 at 17:49, 4 months 14 days ago Marinomed Biotech AG : Augmentation de capital et perspectives financières pour 2025 Augmentation De Capital Marinomed Résultats 2025 Déficit De Liquidités Opportunité Pour Les Actionnaires
PRESS RELEASE published on 03/23/2026 at 17:44, 4 months 14 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out
Published on 08/07/2026 at 00:45, 5 hours 9 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 6 hours 39 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 7 hours 39 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 7 hours 49 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 7 hours 54 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 22:15, 7 hours 39 minutes ago BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 8 hours 9 minutes ago FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 10 hours 49 minutes ago Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 11 hours 29 minutes ago EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:26, 11 hours 28 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 11 hours 28 minutes ago Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 12 hours 8 minutes ago Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 12 hours 9 minutes ago Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 12 hours 9 minutes ago Declaration of voting rights at the end of July 2026
